ATAI insider transaction filings
AtaiBeckley Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-11. Screen ATAI transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 18 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings by 3 insiders — 192,579 shares, $938,031 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 105.
- Largest priced transaction: sale of 100,000 shares @ $4.96 ($496,000) by HERSHBERG ROBERT, filed 2026-07-09.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| HERSHBERG ROBERT — Director | 2 | — | 1 leg · 100,000 sh · $496,000 | 9 |
| Kochendoerfer Gerd — Chief Operating Officer | 2 | — | 1 leg · 50,000 sh · $250,000 | 5 |
| Craig Kevin James — Chief Medical Officer | 2 | — | 1 leg · 42,579 sh · $192,031 | 12 |
| Barrett Christopher Ryan Cave — See remarks | 1 | — | — | 11 |
| Rao Srinivas — See remarks, Director | 1 | — | — | 11 |
| Angermayer Christian — Director, 10% owner & Apeiron Investment Group Ltd. — 10% owner | 1 | — | — | 10 |
| Short Glenn Frank — Chief Scientific Officer | 1 | — | — | 10 |
| Johnson Anne Nagengast — Chief Accounting Officer | 1 | — | — | 9 |
| Kalali Amir H — Director | 1 | — | — | 6 |
| Smiley Andrea Heslin — Director | 1 | — | — | 6 |
+5 more insiders in the window, not shown — every filing appears in the table below.
Recent Form 4 filings — AtaiBeckley Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Angermayer Christian — Director, 10% owner Apeiron Investment Group Ltd. — 10% owner | Disposition to issuer (D): 559,232 · Disposition to issuer (D): 53,398,214 · Disposition to issuer (D): 1,799,302 · Disposition to issuer (D): 624,000 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 17,930 (derivative) · +4 more | EDGAR |
| 2026-09-11 | 4 | JOHNSON SABRINA MARTUCCI — Director | Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative) | EDGAR |
| 2026-09-11 | 4 | HERSHBERG ROBERT — Director | Disposition to issuer (D): 48,858 (derivative) · Disposition to issuer (D): 404,869 (derivative) · Disposition to issuer (D): 62,394 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative) | EDGAR |
| 2026-09-11 | 4 | Rao Srinivas — See remarks, Director | Disposition to issuer (D): 212,942 · Disposition to issuer (D): 3,500 · Disposition to issuer (D): 650,795 (derivative) · Disposition to issuer (D): 217,778 (derivative) · Disposition to issuer (D): 2,147,408 (derivative) · Disposition to issuer (D): 777,400 (derivative) · +5 more | EDGAR |
| 2026-09-11 | 4 | Braunstein Scott — Director | Disposition to issuer (D): 206,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 56,818 (derivative) · Disposition to issuer (D): 208,063 (derivative) | EDGAR |
| 2026-09-11 | 4 | Smiley Andrea Heslin — Director | Disposition to issuer (D): 4,666 · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative) | EDGAR |
| 2026-09-11 | 4 | Kalali Amir H — Director | Disposition to issuer (D): 4,666 · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 64,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative) | EDGAR |
| 2026-09-11 | 4 | Hoffman John Francis — Director | Disposition to issuer (D): 206,000 (derivative) · Disposition to issuer (D): 121,968 (derivative) | EDGAR |
| 2026-09-11 | 4 | Fischer Laurent — Director | Disposition to issuer (D): 206,000 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative) | EDGAR |
| 2026-09-11 | 4 | Faerm Michael E. — Chief Financial Officer | Disposition to issuer (D): 1,275,000 (derivative) · Disposition to issuer (D): 285,000 (derivative) | EDGAR |
| 2026-09-11 | 4 | Short Glenn Frank — Chief Scientific Officer | Disposition to issuer (D): 42,333 · Disposition to issuer (D): 283,280 (derivative) · Disposition to issuer (D): 329,552 (derivative) · Disposition to issuer (D): 180,000 (derivative) · Disposition to issuer (D): 71,620 (derivative) · Disposition to issuer (D): 250,000 (derivative) · +4 more | EDGAR |
| 2026-09-11 | 4 | Barrett Christopher Ryan Cave — See remarks | Disposition to issuer (D): 155,066 · Disposition to issuer (D): 347,000 (derivative) · Disposition to issuer (D): 284,832 (derivative) · Disposition to issuer (D): 231,900 (derivative) · Disposition to issuer (D): 71,620 (derivative) · Disposition to issuer (D): 400,000 (derivative) · +5 more | EDGAR |
| 2026-09-11 | 4 | Johnson Anne Nagengast — Chief Accounting Officer | Disposition to issuer (D): 140,045 · Disposition to issuer (D): 326,416 (derivative) · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 71,620 (derivative) · Disposition to issuer (D): 500,000 (derivative) · Disposition to issuer (D): 550,000 (derivative) · +3 more | EDGAR |
| 2026-09-11 | 4 | Craig Kevin James — Chief Medical Officer | Disposition to issuer (D): 8,437 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 50,400 (derivative) · Disposition to issuer (D): 28,608 (derivative) · Disposition to issuer (D): 372,701 (derivative) · Disposition to issuer (D): 673,808 (derivative) · +2 more | EDGAR |
| 2026-09-11 | 4 | Kochendoerfer Gerd — Chief Operating Officer | Disposition to issuer (D): 1,400,000 (derivative) · Disposition to issuer (D): 675,000 (derivative) · Disposition to issuer (D): 150,000 (derivative) | EDGAR |
| 2026-07-09 | 4 | HERSHBERG ROBERT — Director | Option exercise (M): 48,858 @ $1.35 · Option exercise (M): 51,142 @ $1.35 · Sale (S): 100,000 @ $4.96 · Option exercise (M): 48,858 (derivative) @ $0 · Option exercise (M): 51,142 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Craig Kevin James — Chief Medical Officer | Option exercise (M): 33,051 @ $1.50 · Option exercise (M): 9,528 @ $1.18 · Sale (S): 42,579 @ $4.51 · Option exercise (M): 33,051 (derivative) @ $0 · Option exercise (M): 9,528 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Kochendoerfer Gerd — Chief Operating Officer | Option exercise (M): 50,000 @ $1.60 · Sale (S): 50,000 @ $5 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Hoffman John Francis — Director | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Angermayer Christian — Director, 10% owner | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Smiley Andrea Heslin — Director | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Braunstein Scott — Director | Grant/award (A): 121,968 (derivative) @ $0 · Grant/award (A): 86,095 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Kalali Amir H — Director | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Fischer Laurent — Director | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | HERSHBERG ROBERT — Director | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | JOHNSON SABRINA MARTUCCI — Director | Grant/award (A): 121,968 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Craig Kevin James — Chief Medical Officer | Option exercise (M): 27,280 @ $1.50 · Option exercise (M): 15,299 @ $1.84 · Sale (S): 42,579 @ $5 · Option exercise (M): 27,280 (derivative) @ $0 · Option exercise (M): 15,299 (derivative) @ $0 | EDGAR |
| 2026-04-10 | 4 | Angermayer Christian — Director, 10% owner Apeiron Investment Group Ltd. — 10% owner | Option exercise (M): 46,070 @ $1.88 · Option exercise (M): 410,162 @ $1.64 · Option exercise (M): 103,000 @ $1.34 · Option exercise (M): 46,070 (derivative) @ $0 · Option exercise (M): 410,162 (derivative) @ $0 · Option exercise (M): 103,000 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Craig Kevin James — Chief Medical Officer | Option exercise (M): 76,224 @ $1.18 · Option exercise (M): 23,776 @ $1.50 · Sale (S): 100,000 @ $3.55 · Option exercise (M): 76,224 (derivative) @ $0 · Option exercise (M): 23,776 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Faerm Michael E. — Chief Financial Officer | Grant/award (A): 1,275,000 (derivative) @ $0 · Grant/award (A): 285,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Barrett Christopher Ryan Cave — See remarks | Grant/award (A): 675,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Craig Kevin James — Chief Medical Officer | Grant/award (A): 675,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Short Glenn Frank — Chief Scientific Officer | Grant/award (A): 675,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Kochendoerfer Gerd — Chief Operating Officer | Grant/award (A): 675,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Johnson Anne Nagengast — Chief Financial Officer | Grant/award (A): 525,000 (derivative) @ $0 · Grant/award (A): 117,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Rao Srinivas — See remarks | Grant/award (A): 1,988,000 (derivative) @ $0 · Grant/award (A): 442,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Feilding-Mellen Cosmo — Director | Sale (S): 39,594 @ $3.90 | EDGAR |
| 2025-11-26 | 4 | Feilding-Mellen Cosmo — Director | Disposition to issuer (D): 40,400 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Feilding-Mellen Cosmo — Director | Grant/award (A): 7,702,990 · Grant/award (A): 103,000 (derivative) @ $0 · Grant/award (A): 40,400 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Braunstein Scott — Director | Grant/award (A): 56,818 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | HERSHBERG ROBERT — Director | Grant/award (A): 456,011 (derivative) @ $0 · Grant/award (A): 97,716 (derivative) @ $0 · Grant/award (A): 62,394 (derivative) @ $0 · Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Barrett Christopher Ryan Cave — See Remarks | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | Apeiron Investment Group Ltd. — 10% owner Angermayer Christian — Director, 10% owner | Conversion (C): 2,367,200 · Conversion (C): 147,950 (derivative) | EDGAR |
| 2025-08-18 | 4 | Apeiron Investment Group Ltd. — 10% owner Angermayer Christian — Director, 10% owner | Purchase (P): 8,675,799 @ $2.19 | EDGAR |
| 2025-08-15 | 4 | Rao Srinivas — See Remarks | Grant/award (A): 650,794 (derivative) @ $0 · Grant/award (A): 217,777 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | Smiley Andrea Heslin — Director | Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | Braunstein Scott — Director | Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | Kalali Amir H — Director | Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | Fischer Laurent — Director | Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | JOHNSON SABRINA MARTUCCI — Director | Grant/award (A): 103,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — AtaiBeckley Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-11 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-08-31 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-03 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ATAI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →